CMS stresses doctors' rights to challenge data collected under Sunshine Act
CHICAGO--Centers for Medicare & Medicaid Services policymakers rolling out the Physician Payments Sunshine Act June 17 attempted to soothe physicians' fears over potentially false or misleading reports pointing to dubious financial relationships with medical device and pharmaceutical manufacturers. Anita Griner, CMS's deputy director for the Data Sharing & Partnership Group, said data accuracy is the agency's top priority as it implements the Sunshine Act, created under Section 6002 of the Affordable Care Act. In line with that goal, Griner said CMS is creating a range of educational tools to orient stakeholders toward their compliance responsibilities.
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- CA Powers Up $80M HIE to 'Create Value in the Data'
- TJC Warns Hospitals of Deadly Medical Tubing Mistakes
- 3 Traits Personality Assessments Can't Reveal
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Consumerism Drives Healthcare Branding, Rebranding Efforts